secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2026-09-23T20:13:57+00:00
Accession:  0001193125-26-399416
Event type: litigation
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta settles patent litigations with REGENXBIO and UPenn for $39M
--------------------------------------------------------------------

- Sarepta to pay REGENXBIO $39.0M lump sum within 10 days to settle patent disputes over AAVrh74 capsid and ELEVIDYS.
- Settlement resolves infringement claims involving U.S. Patents 11,680,274 and 10,526,617; releases Sarepta and Catalent from past claims.
- Parties agree to dismiss pending litigations with prejudice; no admission of liability; each bears own costs.
- Company had recorded $39.0M litigation contingency charge in Q2 2026 related to anticipated settlement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000119312526399416/0001193125-26-399416-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000119312526399416/srpt-20260923.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-399416

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer